Larimar Therapeutics, Inc. (LRMR) |
| 4.29 -0.26 (-5.71%) 10-10 11:44 |
| Open: | 4.53 |
| High: | 4.54 |
| Low: | 4.17 |
| Volume: | 1,217,656 |
| Market Cap: | 367(M) |
| PE Ratio: | -2.73 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 6.27 |
| Resistance 1: | 5.37 |
| Pivot price: | 4.47 |
| Support 1: | 3.97 |
| Support 2: | 3.10 |
| 52w High: | 9.5 |
| 52w Low: | 1.61 |
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Financials
| EPS | -1.570 |
| Book Value | 1.870 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -35.0 |
| Return on Equity (ttm) | -60.3 |
Company news
Fri, 10 Oct 2025
Larimar Therapeutics (NASDAQ:LRMR) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Thu, 09 Oct 2025
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Wed, 08 Oct 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR - PR Newswire
Sat, 04 Oct 2025
Will Positive Nomlabofusp Study Results Alter Larimar Therapeutics' (LRMR) Standing in Rare Disease Treatment? - Yahoo Finance
Fri, 03 Oct 2025
Do Positive Friedreich's Ataxia Study Results Shift Larimar Therapeutics’ (LRMR) Long-Term Value Proposition? - simplywall.st
Fri, 03 Oct 2025
Why Larimar Therapeutics (LRMR) Is Up After Positive Long-Term Results for Friedreich's Ataxia Therapy - Sahm
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
